For fifteen years the Biomedical Computing Shared Resource (BCSR) has promoted high quality innovate cancer research by providing members of the UWCCC with an advanced biomedical computing environment. As a matter of policy, computing support within the University and Medical School is decentralized and largely the responsibility of individual departments and centers such as the UWCCC. Within this context, the BCSR plays an essential role by providing both technical and intellectual resources that address the unique and specific needs of the UWCCC in an efficient and cost effective manner. The BCSR supports the UWCCC research enterprise in five years. First, it is responsible for much of the network and I/T infrastructure used on a daily basis by every connected UWCCC member. Second, it provides an array of computing services to UWCCC investigators, other shared resources, and to UWCCC administration. Third, it develops and maintains specialized research resources targeted to the particular needs of UWCCC investigators. Fourth, BCSR staff provide critical software engineering, project management and computer science expertise for specific projects. Fifth, the staff of the BCSR fulfill an important leadership role by tracking or anticipating the needs of the UWCCC research community and then developing the resources to meet these needs. The facilities of the BCSR have been used by Drs. Gould, Moser and Newton to build genetic maps of mice and rats. Drs. Newton and Reznikoff have used them to test new methods for assessing gene loss. Drs. Lindstrom and Kinsella have used these facilities to assess models for therapeutic radiation damage to tumors. Drs. Love and Sondel have used these facilities to build and maintain research databases. In addition, the facilities and staff of the BCSR are used by scientific-oriented shared resources such as the Clinical Trials Research Office for patient and protocol tracking, the Analytical Instrumentation Laboratory and Flow Cytometry for computing support and consultation, and the Biostatistics Shared Resource for computational and database resources. The BCSR also provides essential support and services to UWCCC Administration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-26
Application #
6268766
Study Section
Project Start
1998-06-24
Project End
1999-03-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
26
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Zaitoun, Ismail S; Cikla, Ulas; Zafer, Dila et al. (2018) Attenuation of Retinal Vascular Development in Neonatal Mice Subjected to Hypoxic-Ischemic Encephalopathy. Sci Rep 8:9166
Hart, Vicki; Trentham-Dietz, Amy; Berkman, Amy et al. (2018) The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study. Qual Life Res 27:1237-1247
Lee, Hye Jin; Ehlerding, Emily B; Cai, Weibo (2018) Antibody-Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases. Chembiochem :
Elsaid, Mohamed Y; Shahi, Ankita; Wang, Albert R et al. (2018) Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther 17:2320-2328
Dennison, Kirsten L; Chack, Aaron C; Hickman, Maureen Peters et al. (2018) Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases. PLoS One 13:e0204727
Jamali, Nasim; Sorenson, Christine M; Sheibani, Nader (2018) Vitamin D and regulation of vascular cell function. Am J Physiol Heart Circ Physiol 314:H753-H765
Liu, Zhen; Ehlerding, Emily B; Cai, Weibo et al. (2018) One-step synthesis of an 18F-labeled boron-derived methionine analog: a substitute for 11C-methionine? Eur J Nucl Med Mol Imaging 45:582-584
Chakravarty, Rubel; Siamof, Cerise M; Dash, Ashutosh et al. (2018) Targeted ?-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine. Am J Nucl Med Mol Imaging 8:247-267
Albertini, Mark R; Yang, Richard K; Ranheim, Erik A et al. (2018) Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother 67:1647-1658
Saghiri, Mohammad Ali; Asatourian, Armen; Nguyen, Eric H et al. (2018) Hydrogel Arrays and Choroidal Neovascularization Models for Evaluation of Angiogenic Activity of Vital Pulp Therapy Biomaterials. J Endod 44:773-779

Showing the most recent 10 out of 1528 publications